Search | IOVS | ARVO Journals

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Articles June 2020

Development and Optimization of Freeze-Dried Eye Drops Derived From Plasma Rich in Growth Factors Technology

PDF

Eduardo Anitua; María de la Fuente; Ignacio Alcalde; Cristina Sanchez; Jesús Merayo-Lloves; Francisco Muruzabal
TAGS: eyedrops, freeze drying, growth factor, plasma
Trans. Vis. Sci. Tech.. 2020; 9(7):35. doi: https://doi.org/10.1167/tvst.9.7.35

ARVO Annual Meeting Abstract July 2019

Blue light-cytotoxic protection of plasma rich in growth factors (PRGF-Endoret) in retinal pigment epithelium cells

Sabino Padilla; Maria de la Fuente; Francisco Muruzabal; Borja de la Sen; Susana Del Olmo-Aguado; Carlota Suarez-Barrio; Jesus Merayo-Lloves; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1692. doi:

ARVO Annual Meeting Abstract July 2019

PRGF enhances RPE cell survival

Carlota Suárez Barrio; Susana Del Olmo-Aguado; Claudia Nuñez; Maria de la Fuente; Francisco Muruzabal; Gorka Orive; Eduardo Anitua; Neville N. Osborne; Jesús M. Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1693. doi:

ARVO Annual Meeting Abstract September 2016

PRGF-Endoret®: A new approach in the treatment of limbal stem cell deficiency.

Jesus Merayo-Lloves; Ana Cristina Riestra; Alvaro Meana; Natalia Vazquez; Manuel Chacon; Mairobi Persinal; Gorka Orive; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4350. doi:

ARVO Annual Meeting Abstract June 2015

PRGF-Endoret® in corneal tissue engineering

Ana Cristina Riestra; Natalia Vázquez; Manuel Chacón; Eva García; Alvaro Meana; Gorka Orive; Eduardo Anitua; Jesus Merayo-Lloves

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2261. doi:

ARVO Annual Meeting Abstract June 2015

Long-term biological stability of PRGF-Endoret eye drops: effect of temperature and dosage

Gorka Orive; Maria de la Fuente; Ana Cristina Riestra; Jesus Merayo-Lloves; Francisco Jose Muruzabal; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):730. doi:

ARVO Annual Meeting Abstract June 2015

Effects of autologous serum and plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface myofibroblast differentiation.

Francisco Jose Muruzabal; Maria de la Fuente; Ana Cristina Riestra; Jesus Merayo-Lloves; Gorka Orive; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):734. doi:

ARVO Annual Meeting Abstract April 2014

Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops at different temperature conditions for 24 hours.

Gorka Orive; Francisco Jose Muruzabal; Ander Pino; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4688. doi:

ARVO Annual Meeting Abstract April 2014

Comparing the biological outcomes of autologous serum versus plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface wound healing.

Francisco Jose Muruzabal; Maria De la Fuente; Jesus Merayo-Lloves; Gorka Orive; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4689. doi:

ARVO Annual Meeting Abstract April 2014

PRGF-Endoret® as a substitute of Fetal Bovine Sera for the culture of human corneal limbal stem cells.

Jesus Merayo-Lloves; Alvaro Meana; Ana C Riestra; Natalia Vázquez; Manuel Chacón; Gorka Orive; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4695. doi:

ARVO Annual Meeting Abstract June 2013

Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops after 3 months of storage

Gorka Orive; Francisco Jose Muruzabal; Ander Pino; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3887. doi:

ARVO Annual Meeting Abstract June 2013

Proteome study of keratocytes after PRGF-Endoret treatment

Francisco Jose Muruzabal; Gorka Orive; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3888. doi:

ARVO Annual Meeting Abstract March 2012

Plasma Rich in Growth Factors (PRGF-Endoret) accelerates corneal wound healing after PRK eye surgery, reducing haze formation

Gorka Orive; Ignacio Alcalde; Francisco Muruzabal; Maria de la Fuente; Ana Fernandez; Jesus Merayo-Lloves; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3537. doi:

ARVO Annual Meeting Abstract March 2012

Autocrine protein expression of cells from the ocular surface after treatment with Plasma Rich in Growth Factors (PRGF-Endoret)

Francisco Jose Muruzabal; Maria de la Fuente; Gorka Orive; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4748. doi:

Cornea August 2011

Plasma Rich in Growth Factors (PRGF-Endoret) Stimulates Proliferation and Migration of Primary Keratocytes and Conjunctival Fibroblasts and Inhibits and Reverts TGF-β1–Induced Myodifferentiation

PDF

Eduardo Anitua; Mikel Sanchez; Jesus Merayo-Lloves; Maria De la Fuente; Francisco Muruzabal; Gorka Orive
TAGS: conjunctiva, fibroblasts, growth factor, keratocytes, myofibroblasts, plasma
Invest. Ophthalmol. Vis. Sci.. 2011; 52(9):6066-6073. doi: https://doi.org/10.1167/iovs.11-7302

ARVO Annual Meeting Abstract April 2011

Effect Of Plasma Rich In Growth Factors (PRGF) On Corneal Epithelial Wound Healing

Eduardo Anitua; Francisco Muruzabal; Maria De la Fuente; Jesús Merayo; Gorka Orive

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1991. doi:

ARVO Annual Meeting Abstract April 2011

Effectiveness of Heated Hematic Derivatives (Autologous Serum & Plasma Rich in Growth Factors) in Corneal Epithelial Wound Healing

Claudia Nunez; Jesus Merayo-Lloves; Guilherme Ferrara; Ignacio Alcalde; Manuel Chacon; Carlos Alonso-Ron; Eduardo Anitua

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1998. doi:

ARVO Annual Meeting Abstract April 2011

Plasma Rich In Growth Factors (PRGF) Stimulate Scarness Wound Healing In The Stromal Cells Of The Ocular Surface Tissues

Gorka Orive; Eduardo Anitua; Francisco Muruzabal; Maria De la Fuente; Jesús Merayo

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2002. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development and Optimization of Freeze-Dried Eye Drops Derived From Plasma Rich in Growth Factors Technology

Blue light-cytotoxic protection of plasma rich in growth factors (PRGF-Endoret) in retinal pigment epithelium cells

PRGF enhances RPE cell survival

PRGF-Endoret®: A new approach in the treatment of limbal stem cell deficiency.

PRGF-Endoret® in corneal tissue engineering

Long-term biological stability of PRGF-Endoret eye drops: effect of temperature and dosage

Effects of autologous serum and plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface myofibroblast differentiation.

Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops at different temperature conditions for 24 hours.

Comparing the biological outcomes of autologous serum versus plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface wound healing.

PRGF-Endoret® as a substitute of Fetal Bovine Sera for the culture of human corneal limbal stem cells.

Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops after 3 months of storage

Proteome study of keratocytes after PRGF-Endoret treatment

Plasma Rich in Growth Factors (PRGF-Endoret) accelerates corneal wound healing after PRK eye surgery, reducing haze formation

Autocrine protein expression of cells from the ocular surface after treatment with Plasma Rich in Growth Factors (PRGF-Endoret)

Plasma Rich in Growth Factors (PRGF-Endoret) Stimulates Proliferation and Migration of Primary Keratocytes and Conjunctival Fibroblasts and Inhibits and Reverts TGF-β1–Induced Myodifferentiation

Effect Of Plasma Rich In Growth Factors (PRGF) On Corneal Epithelial Wound Healing

Effectiveness of Heated Hematic Derivatives (Autologous Serum & Plasma Rich in Growth Factors) in Corneal Epithelial Wound Healing

Plasma Rich In Growth Factors (PRGF) Stimulate Scarness Wound Healing In The Stromal Cells Of The Ocular Surface Tissues

To View More...

You must be signed into an individual account to use this feature.